Bipinesh Sansar

7PUBLICATIONS
46CO-AUTHORS
Molecular targetsGenetic immunologyMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 20, 2026
KRAS-Targeted Therapies in NSCLC: Resistance, Combination Strategies, and Emerging Clinical Paradigms.

|Aug 13, 2026
Uncovering Hereditary Risk: Germline Homologous Recombination Repair Variant Spectrum in a Large North Indian Cancer Cohort (INSIGHT-HRR).

|Aug 12, 2026
Carbapenem Resistance in India: A Systematic Review of Epidemiology, Diagnostic Strategies, and Therapeutic Approaches.

|Jun 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

|Feb 23, 2026
Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.

Akhil Kapoor, Ajay Kumar Singh, Mahesh Chaudhary

|Oct 16, 2025
Extravasation with systemic anti-cancer directed therapy administration at daycare in a tertiary care oncology centre: Insights from a prospective observational study (EXACT study).

Bipinesh Sansar, Akhil Kapoor, Anuj Gupta

Pageof 2

Frequent Collaborators

7 joint publications

Akhil Kapoor

6 joint publications

Anuj Gupta

4 joint publications

Bal Krishna Mishra

3 joint publications

Shashikant Patne